40 results
8-K
EX-99.1
MRZM
Marizyme, Inc.
16 Nov 21
Marizyme Is Pleased to Announce the Appointment of David Barthel As Ceo
5:00pm
an innovative point-of-care lab-on-chip digital diagnostic device technologies for chronic kidney disease. In less than a year, Mr. Barthel led the Company from … Logic developed the MATLOC technology, an innovative technology that has strong potential to improve the lives of millions of patients with chronic
8-K
EX-99.1
MRZM
Marizyme, Inc.
27 Dec 21
Marizyme Announces the Closing of My Health Logic
6:09am
the three leading biomarkers for chronic kidney disease (CKD), a disease estimated to affect 37 million Americans – or one out of every seven people … , the Company plans to explore other biomarkers for chronic diseases to be measured at point-of-care.
Acquisition of Senior Officers and New Appointments
8-K
EX-99.2
MRZM
Marizyme, Inc.
10 May 23
Marizyme Announces IP Developments for DuraGraft® and its Pipeline Products
8:30am
of a graft or graft contact area, a chronic or an acute wound, or a burn wound, and to treat reflux, oral mucositis, and aphtha.
Additionally, a patent … microfluidic chip for chronic kidney disease assessment.
Marizyme’s global patent and IP portfolio is managed by Dentons US LLP, the world’s largest
8-K
MRZM
Marizyme, Inc.
5 Nov 21
Entry into a Material Definitive Agreement
5:17pm
.’s mission is to empower people with the ability to get early detection anytime, anywhere with actionable digital management for chronic kidney
8-K
EX-99.1
xwe0i lyifd8seevl
10 May 23
Marizyme Announces IP Developments for DuraGraft® and its Pipeline Products
8:30am
8-K
4r9evkyrfg3fhgmimyw
16 Nov 21
Marizyme Is Pleased to Announce the Appointment of David Barthel As Ceo
5:00pm
8-K
lpe6 box3z
27 Dec 21
Marizyme Announces the Closing of My Health Logic
6:09am
424B3
a0d pdqcvrg85rpf6
17 Oct 23
Prospectus supplement
5:10pm